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Abstract
Background
Although 5-HTTLPR has been shown to influence the risk of life stress-induced depression
in the majority of studies, others have produced contradictory results, possibly due to weak
effects and/or sample heterogeneity.
Methods
In the present study we investigated how age, type and intensity of life-stressors modulate
the effect of 5-HTTLPR on depression and anxiety in a European population cohort of over
2300 subjects. Recent negative life events (RLE), childhood adversity (CHA), lifetime de-
pression, Brief Symptoms Inventory (BSI) depression and anxiety scores were determined
in each subject. Besides traditional statistical analysis we calculated Bayesian effect
strength and relevance of 5-HTTLPR genotypes in specified models.
Results
The short (s) low expressing allele showed association with increased risk of depression re-
lated phenotypes, but all nominally significant effects would turn to non-significant after cor-
rection for multiple testing in the traditional analysis. Bayesian effect strength and relevance
analysis, however, confirmed the role of 5-HTTLPR. Regarding current (BSI) and lifetime
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depression 5-HTTLPR-by-RLE interactions were confirmed. Main effect, with other words
direct association, was supported with BSI anxiety. With more frequent RLE the prevalence
or symptoms of depression increased in ss carriers. Although CHA failed to show an inter-
action with 5-HTTLPR, in young subjects CHA sensitized towards the depression promoting
effect of even mild RLE. Furthermore, the direct association of anxiety with the s allele was
driven by young (30) individuals.
Limitations
Our study is cross-sectional and applies self-report questionnaires.
Conclusions
Albeit 5-HTTLPR has only weak/moderate effects, the s allele is directly associated with
anxiety and modulates development of depression in homogeneous subgroups.
Introduction
Depression is well-known to be a polygenic and multifactorial condition, and although it shows a
moderate degree of inheritance and genetic factors account for a moderate portion of its variabili-
ty, the contribution of each individual gene seems to be small and influenced by other genetic
and environmental factors [1,2]. One of the most investigated genetic polymorphisms regarding
gene-by-environment interaction (GxE) and depression is 5-HTTLPR, a functional polymor-
phism in the upstream regulatory region of the serotonin transporter gene (5-HTT, SLC6A4).
5-HTTLPR is a repeat length polymorphism that has been shown to affect the efficiency of
serotonin uptake and thus synaptic and extracellular serotonin concentrations in the brain.
The short (s) allele of 5-HTTLPR which shows a reduced transcriptional efficiency compared
to the long (l) variant predisposes to cognitive vulnerability to stress-sensitivity including anxi-
ety-related personality traits such as neuroticism [3], or amygdala reactivity to aversive stimuli
[4] which are risk factors for major depressive disorder (MDD) [5,6]. Collier et al. [7] suggested
that there is a significant, although weak, association between depression and 5-HTTLPR s al-
lele. Subsequently, primate studies demonstrated that the effect of the 5-HTTLPR s allele on se-
rotonin function in the central nervous system and on behavior is modulated by early rearing
conditions providing the first evidence for GxE [8,9].
In the case of human depression, two main environmental psychosocial factors were identi-
fied, childhood adversity (CHA) and recent negative life events (RLE), which usually precede
the development of episodes [1]. Caspi et al [10] reported that 5-HTTLPR s allele modulates
the effects of stressful life events in the development of depression. Although numerous genetic
epidemiological studies replicated the initial findings, there are also non-replications and part
replications, and even meta-analyses draw differing conclusions (see, e.g. [11,12]). The failure
of genome-wide association studies (GWAS) to detect risk genes for MDD [13] further empha-
size that depression as a diagnosis is genetically and phenotypically heterogeneous and delinea-
tion of more homogeneous specific sub-categories and inclusion of depression-related
phenotypes are necessary to identify genetic risk factors [2,14,15]. To explore this concept, in
our sufficiently large population we investigated depression-related phenotypes, such as life-
time depression, Brief Symptom Inventory current depression and anxiety scores to determine
whether 5-HTTLPR has similar effects on these measures and whether 5-HTTLPRmodulates
5-HTTLPR, Depression and Anxiety
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the effects of life events in the development of these phenotypes. We specifically tested whether
age and presence of CHA affects the modifying role of 5-HTTLPR on the effect of RLE. To
overcome the limitation of traditional (frequentist) statistical GxE analysis methods which
have limited power to detect biological interactions [16], we calculated the Bayesian relevance
of 5-HTTLPR genotypes in specified models and the ratio of risk of these phenotypes conveyed
by the ss genotype after low, medium and high exposure to life stressors.
Methods
The reported studies were part of the EU funded NewMood study (New Molecules in Mood
Disorders, Sixth Framework Program of the EU, LSHM-CT-2004–503474) approved by the
local Ethics Committees (North Manchester Local Research Ethics Committee, Manchester,
UK; Scientific and Research Ethics Committee of the Medical Research Council, Budapest,
Hungary) and carried out in accordance with the Declaration of Helsinki. All participants pro-
vided written informed consent before participating in the study. All the relevant data are in-
cluded in the paper and Supporting Information file (S2 File).
Subjects aged 18–60 years and of European white origin were recruited through general
practices, advertisements and a web-site from Greater Manchester, UK (n = 1355) and through
general practices and advertisements from Budapest, Hungary (n = 1003). All willing subjects
were included who filled out the NewMood questionnaire pack, English or Hungarian version
as appropriate, and provided DNA by using a genetic saliva sampling kit. Details of responses
have been published previously [17,18].
The NewMood questionnaire included items covering background information (age, eth-
nicity, and family circumstances), personal and family psychiatric history and brief standard
and validated questionnaires covering current mood and anxiety, and life events. A description
of the questionnaires has been published previously [18,19].
In the present study, we analyzed reported lifetime depression (DEP) that was derived from
the background questionnaire and was validated in a subpopulation using the Structured Clini-
cal Interview for DSM-IV (SCID) [20]. Validation data were published recently [17]. Depres-
sive symptoms were measured using the depression items plus the additional items (BSI-DEP),
and anxiety using the anxiety items (BSI-ANX) of the Brief Symptom Inventory (BSI) [21]. A
continuous weighted score (sum of item scores divided by the number of items completed) was
calculated for each BSI variable mentioned above and used in the analysis. For Bayesian analy-
sis the BSI depression and anxiety scores were divided into categorical variables (low, 0–<1;
moderate, 1–<2; severe, 2–4).
We used the List of Life Threatening Experiences questionnaire [22] to identify recent nega-
tive life events (RLE) related to intimate relationships, financial difficulties, illnesses/injuries
and network problems occurring in the last year. The number of life event items was calculated
and used for the initial analysis. Next the scores were grouped into three categories (low = 0–1,
medium = 2, high = 3 or more) based on our previous studies [18,19] and groups were used in
the subsequent analysis and the Bayesian calculations. Childhood Adversity (CHA) questions
related to emotional and physical abuse and emotional and physical neglect were derived from
the Childhood Trauma Questionnaire [23] plus an additional question asked about parental
loss during childhood. The CHA was validated with the full version of the Childhood Trauma
Questionnaire in a subpopulation [17]. The sum of item scores was first calculated and used
and next divided into three categories (low = 0–3, medium = 4–6, high = 7 or more) CHA
based on our previous studies [17] for further statistical analysis.
For genotyping we used buccal mucosa cells collected using a cytology brush (Cytobrush
plus C0012, Durbin PLC) and 2.0 ml of collection buffer in 15-mL plastic tubes. Genomic
5-HTTLPR, Depression and Anxiety
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DNA was extracted according to a published protocol [24]. Determination of 5-HTTLPR geno-
type was performed as previously described [18]. All laboratory work was performed under the
ISO 9001:2000 quality management requirements and was blinded with regard to phenotype.
Statistical analyses were performed with PLINK v1.07 (http://pngu.mgh.harvard.edu/
purcell/plink/) to calculate Hardy-Weinberg equilibrium, and build logistic regression models
for binary outcome variable (DEP) and linear regression models for continuous outcome vari-
ables (BSI-DEP, BSI-ANX). Additive genetic model was applied, sex and age were covariates in
all analyses. The two population data were analyzed together to increase the power, especially
for GxE interaction tests. For power calculation, see Table A in S1 File. Because the 5-
HTTLPRxlife events (RLE or CHA) interaction results were very similar in the first analysis
(see Table B in S1 File) all subsequent statistical calculation used life events as grouped vari-
ables to make it comparable to the Bayesian analysis. Main effects of 5-HTTLPR and 5-
HTTLPRxRLE interaction were separately tested on each outcome variable in the total com-
bined population and separately for subjects who were 30 years of age or below (30) and for
those who were above 30 (>30). Other statistical analyses were performed with IBM SPSS 21.0
for Windows. We also used R Project [25] to support some of the PLINK analyses. All statisti-
cal testing used two-tailed p<0.05 threshold. Because all the calculations attempted to replicate
previously published significant findings, results with nominal p<0.05 and concordant direc-
tion of effect was further investigated and reported, even if they would turn to non-significant
after Bonferroni-correction for multiple testing.
To further characterize the nominally significant findings (either main genotype effects or
the combined effects of GxE interactions) we applied Bayesian relevance analysis [26,27] based
on Bayesian networks [28]. This method applies Bayesian statistics [29] to quantify the strong
relevance of predictors with respect to a selected target as probability scores (posterior proba-
bility of relevance) and allows the detailed investigation of possible effect size of predictors (i.e.
odds ratios). The method performs Bayesian model averaging [30,31], both at structural and
parametric levels, thus handling the multiple hypothesis problem. This approach provides full
Bayesian Odds Ratio measures for the effect size of a predictor, which is a more realistic mea-
sure than e.g. a single model-based confidence interval. To cope with heterogeneity of effects in
various subpopulations, suggested by the scientific literature and our PLINK analysis, we per-
formed separate analyses in subpopulations defined by the recent life event categories, child-
hood adversity categories and/or age (equal or<30 and>30 years of age), respectively. All
odds ratios were estimated using the ll genotype of 5-HTTLPR as a basis. (For details see Sup-
porting Information in S1 File).
Results
The total population and all sub-populations (Manchester and Budapest samples, and subjects
with or without lifetime depression, respectively) were in Hardy-Weinberg equilibrium
(p>0.05). The genotype frequency was not significantly different in the Budapest and Man-
chester samples (pADD = 0.154) which allowed us to carry out mega-analyses in the combined
sample. Description of the population can be seen in Table 1. Increase of either RLE or CHA
exposure positively correlated with BSI depression and anxiety scores, and caused sharp in-
crease in risk of lifetime depression (Supporting Information and Fig. A in S1 File).
5-HTTLPR effects on lifetime depression and BSI depression
5-HTTLPR effects on lifetime depression and BSI depression showed several similarities. Using
regression analysis, there were no significant main effects of 5-HTTLPR genotypes on reported
lifetime depression or on BSI depression (Table 2). However, with the increasing number of s
5-HTTLPR, Depression and Anxiety
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alleles, subjects proved to be more vulnerable to the depressogenic effect of the increasing num-
ber of RLEs (Table 2 and Fig. 1A and 1C, and Table E in S1 File). These interaction effects be-
came non-significant in the two subpopulations split by age, possibly because of decreased
power, although in all cases the s allele remained the risk one (Table 2 and Figs. B-A—B-D in
S1 File). The significant interaction of 5-HTTLPRxRLE was not due to the increased number of
RLE in the s allele carriers. On the contrary, number of RLEs tended to decrease with the in-
creasing number of s alleles (Table C in S1 File).
Bayesian effect strength estimation confirmed that the effect of 5-HTTLPR on depression was
relevant in the presence of RLEs. Namely, ss compared to ll genotype carriers have increased risk
for lifetime depression and have higher BSI depression scores in subjects with medium (DEP:
ORBayesian = 1.24–1.77; BSI-DEP: ORBayesian = 1.29–1.39) or high (DEP: ORBayesian = 1.85–2.4;
BSI-DEP: ORBayesian = 1.67–2.4) RLE (Fig. 1B, 1D) but it has non-relevant effect (ORBayesian1)
in subjects with low RLE. The relatively flat posterior distribution curves in case of high RLE in-
dicate several possible Bayesian Odds Ratio values with moderate or low certainty. Bimodal dis-
tribution for medium RLE subjects suggests that one group of models supports one, and another
group of models supports another odds ratio.
Table 1. Population description.
Demographics
gender male (%) 723 (31%)
female (%) 1635 (69%)
lifetime depression (DEP) no (%) 1380 (59%)
yes (%) 978 (41%)
recent negative life events (RLE) mean +/- SEM 1.21 (0.03)
low (%) 1574 (67%)
medium (%) 442 (19%)
high (%) 338 (14%)
childhood adversity (CHA) mean +/- SEM 3.29 (0.07)
low (%) 1540 (65%)
medium (%) 417 (18%)
high (%) 388 (17%)
age mean +/- SEM 32.79 +/- 0.22
30 (%) 1083 (47%)
>30 (%) 1203 (53%)
current depression score (BSI-DEP) mean +/- SEM 0.85 (0.02)
low (%) 1599 (68%)
moderate (%) 414 (18%)
severe (%) 341 (14%)
current anxiety score (BSI-ANX) mean +/- SEM 0.88 (0.02)
low (%) 1538 (65%)
moderate (%) 472 (20%)
severe (%) 344 (15%)
Genetic variable
5-HTTLPR ss (%) 438 (19%)
sl (%) 1138 (48%)
ll (%) 782 (33%)
SEM: standard error of mean; BSI: Brief Symptom Inventory.
doi:10.1371/journal.pone.0116316.t001
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Fig 1. 5-HTTLPRxRLE interaction, with PLINK (left column) and Bayesian (right column) analyses. LR+: likelihood ratio of emergence of the disease;
BSI: Brief Symptom Inventory; BSI-DEP: BSI depression score; BSI-ANX: BSI anxiety score; DEP: lifetime depression; RLE: recent negative life events (in
the last year). The three categories of RLE are: low = 0–1, medium = 2, high = 3 or more. Numbers in groups: low RLE: ss = 292, sl = 746, ll = 480; medium
RLE: ss = 82, sl = 207, ll = 144; high RLE: ss = 51, sl = 146, ll = 134. Standard errors of means are displayed in case of continuous variables (left column).
Right column figures display outlines of posterior distributions of Bayesian Odds Ratios of 5-HTTLPR ss versus ll genotype with respect to DEP, BSI-DEP
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There were no significant interaction effects of childhood adversity and 5-HTTLPR geno-
types on lifetime depression or on BSI depression scores (Table 2). However, 5-HTTLPRxRLE
interaction on BSI depression scores was significant in those who experienced medium or high
childhood adversity. This remained significant at trend level in the younger age group but did
not approach significance in the older group. In contrast, there was no 5-HTTLPRxRLE inter-
action among subjects with either no childhood adversity or age above 30 (Table D in S1 File).
5-HTTLPR effects on BSI anxiety
Using linear regression analysis, BSI anxiety increased with the increasing number of s alleles
(Table 2 and Fig. 1E, Table E in S1 File), irrespective of recent negative life events. This effect
was significant in the younger (30) subpopulation but was not present in the elder (>30) sub-
population (Table 2, Figs. B-E and B-F in S1 File). However, there was no significant 5-
HTTLPRxRLE interaction on BSI-ANX (Table 2).
Bayesian Odds Ratio estimation implemented in the three (low, medium, high) RLE groups
also support the 5-HTTLPRmain effect seen in PLINK results showing that the odds ratios are
greater than one, irrespective of RLE group (Fig. 1F). The RLE credible intervals are not as sep-
arated as they are for depression phenotypes, where PLINK regression analyses detected
interactional effects.
In the severe vs. low anxiety comparison, Bayesian odds ratio estimation showed firm credi-
ble intervals for the ss vs. ll (ORBayesian = 1.31–1.39) effects, in the total population (Fig. 2). Re-
sults indicate a remarkable difference between the younger (30 years) and the elder (>30)
subpopulations (supporting traditional PLINK results). In the elder subpopulation the effect of
the ss compared to ll genotype of 5-HTTLPR is modest (ORBayesian = 1.13–1.19), in the younger
subpopulation, however, the effect is strong with a firm credible interval ORBayesian = 1.55–1.82
(Fig. 2).
There were no significant interaction effects of childhood adversity and 5-HTTLPR geno-
types on BSI anxiety scores and remained the non-significant 5-HTTLPRxRLE interaction on
BSI-ANX even in those who experienced medium or high childhood adversity (Table 2, and
Table D in S1 File).
The mediating role of BSI anxiety in the 5-HTTLPRxRLE interaction on
depression
Next we tested whether the depressive effect of 5-HTTLPR is mediated by the increased BSI
anxiety scores related to the increasing number of s alleles. When we used BSI anxiety as a co-
variate in the regression models the significant 5-HTTLPRxRLE interaction on lifetime depres-
sion and BSI depression scores became a trend in the total population (Table 2). Involving BSI
anxiety, 5-HTTLPRxRLE trend on lifetime depression also disappeared in the young subpopu-
lation (Table 2). These results suggest that BSI anxiety partially mediates the depressive effect
of 5-HTTLPRxRLE interaction, especially in young people.
(severe vs. low), and BSI-ANX (severe vs. low). Subsets according to RLE categories (low, medium and high) were analyzed individually. Curve flatness
refers to the number of possible models, each with a different odds ratio. An odds ratio greater than one represents a risk for the given phenotype. 1A.
Logistic regression analysis showed that having the more s alleles increased the risk of DEP with increasing number of RLE. 1B. Regarding DEP there is a
clear difference between subjects with low RLE (with a Bayesian Odds Ratio close to 1) and subjects with medium or high RLE (where the effect of ss
genotype is stronger). 1C. As in case of DEP: having the more s alleles also increased BSI-DEP with increasing number of RLE, using linear regression
analysis. 1D. As in case of DEP: effect of ss genotype on BSI-DEP is negligible in the low RLE group, but higher in the medium, and especially high in the
high RLE group. 1E. In contrast to depression phenotypes: linear regression analysis showed that carrying the more s alleles increased BSI-ANX without
interaction with RLE. 1F. In contrast to depression phenotypes, ss genotype represents a risk for BSI-ANX irrespective of RLE group.
doi:10.1371/journal.pone.0116316.g001
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5-HTTLPR effects for the combined, multivariate phenotype in groups
differentially exposed to RLE
Finally we calculated Bayesian probability of relevance for the combined, multivariate pheno-
type using all three measured phenotypes: lifetime depression, BSI depression score, and BSI
anxiety score. Our results demonstrated moderate probability of relevance (Pr = 0.3–0.5) of 5-
HTTLPR in both age groups (Fig. 3A) and childhood adversity groups (Fig. 3B), in those who
had high recent negative life events. In addition, in the younger age group (30) 5-HTTLPR
was strongly relevant in those who had medium or high childhood adversity and even moder-
ate number of recent negative life events (Pr = 0.91 and Pr = 0.69 in moderate and high RLE
groups, respectively; Fig. 3C), while in the older age group (>30) 5-HTTLPR was strongly rele-
vant only in those who had high recent negative life events but this effect was present irrespec-
tive of childhood adversity (Pr = 0.91 and Pr = 0.82 in low and medium-high CHA groups,
respectively; Fig. 3D).
Discussion
According to our results, exposure either to RLE or CHA caused a marked, dose-dependent in-
crease in all three depression-related phenotypes (Supporting Information and Fig. A in S1
File). However, 5-HTTLPR weakly modulated the effect of RLE on lifetime depression and cur-
rent BSI-depression, while in BSI-anxiety it showed a weak main effect, namely a direct associa-
tion with the risk s allele even in individuals having experienced low life stress, and stress
exposure caused only a minor additional increase in anxiety. These weak genetic associations
are in line with the hypothesis that depression and anxiety are highly polygenic and multifacto-
rial disorders [2,13]. This is confirmed also by the GxG interaction effect of 5-HTTLPR with
CB1 receptor gene promoter polymorphisms in the anxiety phenotype, and supported also by
Fig 2. Effect of age on posterior distribution of Bayesian Odds Ratios of 5-HTTLPR on BSI-ANX. BSI:
Brief Symptom Inventory; BSI-ANX: BSI anxiety score. Curves display outlines of posterior distributions of
Bayesian Odds Ratios of 5-HTTLPR ss versus ll genotype with respect to BSI-ANX (severe vs. low). An odds
ratio greater than 1 represents risk for BSI-ANX. Odds ratios are given in different age groups (all population;
equal and below 30; and above 30). All curves are highly peaked that indicates that all the possible models
entail highly similar odds ratios, and the Bayesian Odds Ratio values show a moderate 5-HTTLPR ss
genotype effect in the total population, strong effect in the younger subjects and negligible effects in the
elder subpopulation.
doi:10.1371/journal.pone.0116316.g002
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Fig 3. Bayesian posterior probabilities of relevance of 5-HTTLPR for the multivariate phenotype.RLE was grouped into three categories: low = 0–1,
medium = 2, high = 3 or more number of recent negative life events (in the past year). CHA (childhood adversity) was divided into two categories (based on
the original three): low = 0–3, medium or high = 4 or more scores. Multivariate phenotype (more accurately describes depression related psychiatric state
than one phenotype measure alone) encompasses lifetime depression, BSI depression score and BSI anxiety score. Results are displayed according to
CHA and age, in groups differentially exposed to RLE. 3A and 3B. Results demonstrate moderate Bayesian probability of relevance of 5-HTTLPR in both
age groups and CHA groups in those who had 3 or more RLE. 3C. In the younger age group (30) 5-HTTLPRwas strongly relevant in those who had
medium or high CHA and even moderate number of RLE. 3D. In the older age group (>30) 5-HTTLPR was strongly relevant in those who had 3 or more RLE,
irrespective of CHA.
doi:10.1371/journal.pone.0116316.g003
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animal experiments in anxiety models [32,33]. The direct association of anxiety with the s allele
was stronger in young (30) individuals. In addition, although CHA did not show any interac-
tion with 5-HTTLPR on any of the phenotypes, it had an important influence on the 5-
HTTLPRxRLE interaction. Namely, in young subjects it sensitized towards the effect of RLE
even if RLE was mild, when a combined multivariate outcome was used. In older subjects
(>30) 5-HTTLPR was only relevant when more RLE were reported irrespective of childhood
adversity. The results suggest that the modulatory effects of serotonin transporter gene varia-
tion on the risk of depression may involve different mechanisms in different age groups.
Pleiotropic effect of 5-HTTLPR on depression-related phenotypes
In keeping with previous findings we found genetic effects of 5-HTTLPR in both anxiety and
depression in the predicted direction, namely s allele being a risk variant (Table E in S1 File).
What is more intriguing, is that we replicated a direct association between 5-HTTLPR and anx-
iety [3,34,35] and a 5-HTTLPRxRLE interaction in lifetime and current BSI-depression [10,18]
in a large non-clinical population sample. In addition, we found that anxiety partially mediates
the effect of the 5-HTTLPRxRLE interaction on the emergence of depression, as was previously
hypothesized [36]. These findings may shed new light on the complex and multilevel relation-
ship between different manifestations of increased vulnerability related to 5-HTTLPR as well as
on the relationship between anxious and depressive symptomatology and morbidity. Clinically
there is an extensive correlation between anxiety and depression, reflected not only in the fre-
quent comorbidity between the two conditions but also in the clinical entity of mixed anxiety
and depression in ICD-10, and the shared genetic risk factors between these two phenomena
[2,14]. Our results suggest that 5-HTTLPR is one of the shared genetic factors. However, the
fact that its effects on depression act through anxiety and life stress suggests multiple central
nervous system actions. Important human neuroimaging findings demonstrated that 5-
HTTLPR s allele carriers have greater “tonic” amygdala activation at rest [5], which is in line
with our finding of a direct association between 5-HTTLPR and anxiety. Our GxE findings for
depression suggest that in addition to tonic, a phasic effect of 5-HTTLPR on emotion process-
ing also exists. Indeed, other brain imaging studies showed increased amygdala response to
negative emotional stimuli [4], and indicated an association between the s allele and enhanced
acute stress reactivity in a broader brain network [37].
Stress sensitizing effect of CHA and the effect of 5-HTTLPR
Interestingly, and in contrast to previous results, we could only demonstrate an effect of recent
life events in our interaction models, but not of childhood maltreatment [10,11,14,38]. As a
possible explanation for the discrepancies concerning 5-HTTLPR and different types of life
events it has been suggested that the role of childhood adversity may be more specific to recur-
rent or chronic depression than to single depressive episode occurrences [38,39]. This is in line
with the stress sensitization hypothesis, which suggests that childhood adversity leads to in-
creased vulnerability to adult stressors and thus more psychopathology, especially increased
risk for depression [40]. In our study, childhood adversity sensitized young subjects (30) to
recent negative life events, such that even in the case of medium number of RLE 5-HTTLPR
showed high relevance in the depression-related multivariate phenotype. However, we could
not demonstrate a similar sensitization effect in the older group (>30).
Age and the effect of 5-HTTLPR
The GxE interaction between 5-HTTLPR genotype and environmental adversities on the devel-
opment of depression appears to be a function of several other variable conditions, and also
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seems to be an age dependent effect as it is reported as a significant finding in studies in young
adults but not in adolescents or the elderly [14]. Based on our results, 5-HTTLPR is strongly
relevant in older adults (>30) only in the presence of high number of RLE suggesting that
tonic effect of this polymorphism might weaken with age but robust stress could still elicit pha-
sic effects. As the incidence of depression is also age-dependent, it is not unlikely that in differ-
ent ages and stages of development different factors play a role in the development of
depression, and thus this risk is also influenced by different genetic factors.
Limitations
Besides advantages, there are several limitations of our study to be noted. In our cross-sectional
population sample almost half of the willing participants reported lifetime depression that
might introduce sampling bias. Current (BSI) or lifetime depression and current BSI-anxiety
were assessed via self-report, with no psychiatric screening that might result inaccurate pheno-
type calling. However, our data were validated [17,19] in a subsample during face-to-face inter-
views using the Structured Clinical Interview for DSM-IV (SCID, [20]), the interviewer rated
Montgomery Asberg Depression Rating Scale (MADRS, [41]) and the Clinical Anxiety Scale
(CAS, [42]). Assessment of recent negative life events and childhood adversities was also based
on self-report but again used validated questionnaires as described in the methods section. Our
study was cross-sectional thus no longitudinal effects of life stresses were available and there-
fore persistence of depression and the timing of life events relative to depression onset could
not be determined. And finally, because of the limited power further potentially important fac-
tors such as social support were not included in the analysis.
Implication for future studies
Based on our results the effect of the 5-HTTLPRmight be better captured in specific subgroups
of the population than in large but heterogeneous population samples. Our Bayesian Odds
Ratio calculations demonstrated that in these subgroups the genetic ORs are increased. Such
stratified analyses should result in greater power in future GxE interaction studies (see Table A
in S1 File). In addition, our study demonstrated that the Bayesian network-based methodology,
which was developed to analyze relevance of predictors with respect to a set of phenotypic, clin-
ical and environmental descriptors, is a powerful approach to identify highly relevant genetic
risk factors even when traditional (frequentist) analysis methods are not able to provide
significant results.
Conclusions
In conclusion, our results emphasize that genetic variation in 5-HTTLPR is relevant to the de-
velopment of depressive symptomatology. However its effects are expressed through a multi-
level network of interactions among genes, and between genes and the environment. No doubt
there are several other important modifying variables still to be discovered [43,44,45]. Our re-
sults also indicate how methodological differences between studies may obscure or mask im-
portant associations and emphasize the need for further studies applying sophisticated designs
and alternative mathematical methods to clarify and deepen our understanding of the role of
genetic risk factors for depression and anxiety.
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